According to the report, the global sterile injectable drugs market was valued at approximately USD 369.7 billion in 2017 and is expected to generate around USD 779.9 billion by 2024, at a CAGR of around 11.25% between 2018 and 2024.
New York, NY, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Sterile Injectable Drugs Market by Type (Small Molecules and Large Molecules), by Drug Class (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccine, Immunoglobulin, Blood Factors, and Others), by Indication (Cardiology & Metabolic Disorders, Musculoskeletal, Neurology, Oncology, Autoimmune, Infectious Diseases, and Others), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and E-Commerce): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024”. According to the report, the global sterile injectable drugs market was valued at approximately USD 369.7 billion in 2017 and is expected to generate around USD 779.9 billion by 2024, at a CAGR of around 11.25% between 2018 and 2024.
The increasing preference for large molecule drugs over traditional drugs, rising incidences of chronic diseases, and the requirement of large molecules for the treatment of chronic diseases are major growth factors likely to fuel the sterile injectable drugs market in the future. The rise in the use of biologics, monoclonal antibodies, and antibody-drugs conjugate to treat various diseases is also anticipated to boost the development of this market globally in the estimated time period.
Browse through 71 Tables & 39 Figures spread over 110 Pages and in-depth TOC on “Global Sterile Injectable Drugs Market: By Type, Size, Industry Share, Segments, Analysis and Forecast, 2017—2024”.
Request Free Sample Report of Global Sterile Injectable Drugs Market Report @ https://www.zionmarketresearch.com/sample/sterile-injectable-drugs-market
The sterile injectable drugs market is divided based on type, indication, drug class, and distribution channel. By type, the market is classified into large molecules and small molecules. Large molecules are anticipated to dominate the sterile injectable drugs market. The indication segment comprises musculoskeletal disorders, neurology, oncology, autoimmune, contagious diseases, cardiology and metabolic disorders, and others. Oncology is expected to dominate this market globally, due to the rising prevalence of cancer and research on the effective drugs for treating cancer. By drug class, the sterile injectable drugs market includes insulin, vaccine, peptide hormones, monoclonal antibodies, immunoglobulin, cytokines, blood factors, and others. Monoclonal antibodies are likely to lead this global market, as they can bind to the same epitope through monovalent affinity and carry drugs to help them in triggering the immune system for required responses. By distribution channel, the market includes hospital pharmacy, retail pharmacy, and e-commerce. Hospital pharmacies are projected to dominate the market in the future, owing to the major patient population in hospitals.
North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa comprise the regional segment of the global sterile injectable drugs market. North America is projected to lead the market for sterile injectable drugs in the forecast time period. In 2017, the region held about 42% share of the global sterile injectable drugs market share. The rapid developments made in healthcare infrastructure, the presence of major players in the region, huge investments made in the research and development, and increased adoption of oncology-related drugs in hospitals to treat different cancers are some factors likely to fuel the sterile injectable drugs market in North America. Additionally, the expansion of different companies across the globe to increase their production capacities is anticipated to drive the North American sterile injectable drugs market.
Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/sterile-injectable-drugs-market
The increase in investment witnessed across the healthcare sector, the enforcement of strict government regulations for sterile injectable drugs, the rise in the prevalence of chronic diseases, and rapid technological advancements are likely to support the sterile injectable drugs market in Europe.
The Asia Pacific region is predicted to register the highest rate of growth in the sterile injectable drugs market in the future, owing to the presence of a large patient pool and rising awareness about sterile injectable drugs. The presence of various small pharma companies in India and China, the introduction of different types of policies by various government bodies, and an increase in the investments by companies in developing countries of Asia Pacific are also likely to fuel the market growth for sterile injectable drugs in the Asia Pacific region.
Browse the full “Sterile Injectable Drugs Market by Type (Small Molecules and Large Molecules), by Drug Class (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccine, Immunoglobulin, Blood Factors, and Others), by Indication (Cardiology & Metabolic Disorders, Musculoskeletal, Neurology, Oncology, Autoimmune, Infectious Diseases, and Others), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and E-Commerce): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024” Report at https://www.zionmarketresearch.com/report/sterile-injectable-drugs-market
The Middle Eastern and African and Latin American regions are also anticipated to show rapid growth in the demand for sterile injectable drugs. Continuous investments made by governments and companies for the development of healthcare infrastructure and economic development in various countries of these regions are anticipated to fuel the sterile injectable drugs market in these regions.
Major players of the sterile injectable drugs market include GlaxoSmithKline PLC, Baxter International Inc., AstraZeneca, Johnson & Johnson Services, Inc., Sanofi, Merck & Co., Inc., Gilead Sciences Inc., Pfizer Inc., Novartis AG, and Nova Nordisk A/S, among others.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/sterile-injectable-drugs-market
This report segments the global sterile injectable drugs market into:
Global Sterile Injectable Drugs Market: Type Analysis
- Small Molecules
- Large Molecules
Global Sterile Injectable Drugs Market: Drug Class Analysis
- Monoclonal Antibodies
- Peptide Hormones
- Blood Factors
Global Sterile Injectable Drugs Market: Indication Analysis
- Cardiology and Metabolic Disorders
- Musculoskeletal Disorders
- Neurology Disorders
- Infectious Diseases
Global Sterile Injectable Drugs Market: Distribution Channel Analysis
- Hospital Pharmacy
- Retail Pharmacy
Global Sterile Injectable Drugs Market: Regional Analysis
- North America
- The U.S.
- Asia Pacific
- Latin America
- The Middle East and Africa
- Prescription Dermatology Therapeutics Market: https://www.zionmarketresearch.com/report/prescription-dermatology-therapeutics-market
- Smart Healthcare Products Market: https://www.zionmarketresearch.com/report/smart-healthcare-products-market
- Viral Clearance Market: https://www.zionmarketresearch.com/report/viral-clearance-market
- Insulin Delivery Devices Market: https://www.zionmarketresearch.com/report/insulin-delivery-devices-market
- Ultrasound Probe Disinfection Market: https://www.zionmarketresearch.com/report/ultrasound-probe-disinfection-market
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651